Search results

• List of neurological disorders
  ...or and frequently observed [[neurological disorders]] (e.g., [[Alzheimer's disease]]), symptoms (e.g., [[back pain]]), signs (e.g., [[aphasia]]) and syndromes *[[Alexander disease]]
  10 KB (889 words) - 21:07, 21 September 2010
• List of fictional diseases
  This article is a '''list of [[fiction]]al [[disease]]s''' — nonexistent, named medical conditions which appear in fiction whe ...smission (medicine)|airborne transmission]], and is extremely [[infectious disease|contagious]].
  66 KB (10,587 words) - 21:08, 21 September 2010
• Chronic cerebrospinal venous insufficiency
  {{Infobox disease ...uthor=Zamboni P |title=The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis |journal=J R Soc Med |volume=9
  25 KB (3,509 words) - 21:29, 21 September 2010
• Tetrahydrocannabinol
  New scientific evidence is showing that THC can prevent [[Alzheimer's Disease]] in an [[animal model]] by preventing the inflammation caused by [[microgl |title=Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microgli
  50 KB (6,686 words) - 22:09, 21 September 2010
• Neuromodulation
  [[Parkinson's disease]] is at least in part related to dropping out of dopaminergic cells in [[de
  11 KB (1,374 words) - 22:11, 21 September 2010
• Excitotoxicity
  ...itochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease |journal=[[BMC Neurosci]] |volume=10 |issue= |pages=64 |year=2009 |pmid=195 ...n's disease]], [[alcoholism]] or [[alcohol withdrawal]] and [[Huntington's disease]].<ref name="Kim">Kim AH, Kerchner GA, and Choi DW. Blocking Excitotoxicit
  11 KB (1,547 words) - 22:11, 21 September 2010
• Apamin
  ...]], [[memory disorder]]s, and possibly [[schizophrenia]] and [[Parkinson's disease]].
  9 KB (1,091 words) - 22:12, 21 September 2010
• Low-affinity nerve growth factor receptor
  ...nalling complex as new target for the therapeutic treatment of Parkinson's disease |journal=CNS & Neurological Disorders Drug Targets |volume=7 |issue=6 |page
  13 KB (1,750 words) - 22:12, 21 September 2010
• Dopaminergic nerve fibre
  ...in the [[basal ganglia]] of the brain are known to result in [[Parkinson's Disease]].
  1,019 bytes (139 words) - 22:12, 21 September 2010
• Dextromethorphan
  ...| title=Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase | journal=The FASEB Journal | date=20 January
  26 KB (3,444 words) - 22:15, 21 September 2010
• Trichloroethylene
  ...erated title -->]</ref> according to the [[Agency for Toxic Substances and Disease Registry]] (ATSDR). Under the Safe Drinking Water Act of 1974, and as amend ...ar Veterans), and also with a neurologic syndrome resembling [[Parkinson's disease]] (Gash DM. et al. Ann Neurol. 2008 Feb;63(2):184-92. Trichloroethylene:
  33 KB (4,639 words) - 21:02, 24 September 2010
• Gamma-Hydroxybutyric acid
  ...e beers and wines. [[Succinic semialdehyde dehydrogenase deficiency]] is a disease that causes GHB to accumulate in the blood. ...alcoholism and the effects of various drugs to persons afflicted with said disease for the past ten years. His studies in 1998 note that GHB, as a pharmaceuti
  55 KB (7,839 words) - 21:04, 24 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)